Canopy Growth (TSE:WEED) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Canopy Growth Corporation has reported a 7% increase in net revenue for Q4 FY2024, with revenue from Storz & Bickel soaring by 43% compared to the same quarter the previous year. The company’s Canadian medical cannabis net revenue also saw a significant uptick, rising by 16% in Q4 and 10% over the entire fiscal year. Additionally, Canopy Growth has successfully reduced its Cost of Goods Sold in Canada by 54% and isn’t facing any major debt obligations until March 2026.
For further insights into TSE:WEED stock, check out TipRanks’ Stock Analysis page.
